Neurotech in Switzerland Market Map
Market map and taxonomy
The complete working map contains 51 names: 28 core Swiss neurotechnology companies, 19 adjacent companies and 4 borderline names.
The count is deliberately broader than just BCIs or neuromodulation. Core means direct neural recording, interpretation, stimulation, modulation, repair, restoration or specialist neurological measurement. Adjacent covers rehabilitation robotics, surgical technology, movement sensing and other businesses close enough to the nervous system that leaving them out would give a pretty incomplete picture. Borderline is exactly what it sounds like: companies I think are relevant to the market, but where the technology, use case or Swiss footprint sits just outside the tighter definition.
A couple of important caveats. Aleva Neurotherapeutics remains on the map because it is part of the Swiss neurotech story and got a directional DBS system all the way through CE marking and into the market, but the Lausanne court approved a composition agreement with its unsecured creditors in June 2024. Dandelion Science has a meaningful Geneva connection but a US-Swiss footprint rather than a clean Swiss headquarters story.
The map uses representative city clusters rather than trying to pin all fifty-one companies individually. The full taxonomy is below.
Core neurotech companies (28)
3Brain
ABILITY Neurotech
Aleva Neurotherapeutics
BEE Medic
Bottneuro
Braincredible
BrainQuant
BrainScape Medical
Comphya
dEEGtal
DeepPsy
FinalSpark
HBImed
IDUN Technologies
Infera Neuro
Luciole Medical
machineMD
MaxWell Biosystems
MindMaze
MYNERVA
NeuroGyn
Neurosoft Bioelectronics
Optohive
Positrigo
SaisiR
SensArs
Skaaltec
Xana, Smart Neurostimulation
Adjacent neurotech companies (19)
Altoida
Artiria Medical
Bearmind
Clee Medical
Dividat
Emovo Care
Gondola Medical Technologies
Hocoma
Intento
Lambda Health System
Magnes
MindMetrix
MYOLINK
Nanoflex Robotics
neurodAIgnostics
Reha Technology
Rhovica Neuroimaging
SurgeonsLab
TWIICE
Borderline (4)
Bewe, formerly Neuria
BRNLIT.AI
Connectome Health
Dandelion Science
Of the twenty-eight core names, five are enabling suppliers rather than clinical products, eight haven’t reached a person yet, fourteen have technology in humans in some form and six have products in clinical use. DeepPsy is already reimbursed through Swiss basic health insurance.
There is also a fairly obvious geographic pattern once everything is on one sheet. Geneva repeatedly leads back to Campus Biotech, the Wyss Center and HUG. Lausanne leads back to EPFL and CHUV. Zurich leads back to ETH. Bern and Basel add smaller specialist groups around diagnostics, surgery and stimulation.
You can get from Geneva to Zurich by train in less than three hours. In the US these would probably be separate ecosystems. In Switzerland they’re stops on the same train.
The full article goes into the companies, who is actually in humans, the Swiss investor landscape and why the country seems unusually good at getting difficult neuroscience through the awkward bit between a paper and a patient.
https://theneurotechnewsletter.substack.com/p/neurotech-in-switzerland
As always, corrections and companies I’ve missed are very welcome.